Addiction Education – A Pressing Need
In 2018 about 70,000 people died from an unintentional drug overdose, 80,000 from alcohol, and approximately half a million from…
Daniel Schatz, MD
About Daniel Schatz, MD
Director of Program and Policy, Office of Behavioral Health, Health + Hospitals, NYU Langone
April 12, 2019 by Daniel Schatz, MD
Buprenorphine Best Practices
The New York State Department of Health, the New York State Office of Alcoholism and Substance Abuse (OASAS), and the New York State Buprenorphine Working Group wrote a Best Practice document focused on misconceptions related to the use of buprenorphine for the treatment of opioid use disorder (OUD). NYSAM Board Member, Dr. Dan Schatz, wrote a summary of the document reviewing five misconceptions of buprenorphine treatment.